03 Jun 2013
A UK study presented at the annual American Society of Clinical Oncology meeting, part of a larger international trial, assesses the risk-benefit balance of using tamoxifen for five versus ten years in the treatment of breast cancer.
Call for nominations for Awards Committee Chair
30 Oct 2024
James M Tanner Award - 2025 nominations open
30 Oct 2024
Would you like to host the BSPED annual meeting?
21 Oct 2024